Deutsche Bank Ag\ Kura Oncology, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 43,488 shares of KURA stock, worth $485,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,488

Previous 33,475 29.91%

Holding current value

$485,760

Previous $689,000 23.22%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$18.57 - $23.23 $185,941 - $232,601	10,013 Added 29.91%	43,488 $849,000
Q2 2024 Aug 14, 2024	BUY	$17.53 - $22.98 $4,102 - $5,377	234 Added 0.7%	33,475 $689,000
Q1 2024 May 15, 2024	SELL	$13.42 - $23.53 $4.31 Million - $7.55 Million	-321,038 Reduced 90.62%	33,241 $709,000
Q4 2023 Feb 14, 2024	BUY	$7.58 - $14.38 $2.45 Million - $4.64 Million	322,591 Added 1018.02%	354,279 $5.09 Million
Q3 2023 Nov 09, 2023	BUY	$8.44 - $11.86 $38,309 - $53,832	4,539 Added 16.72%	31,688 $288,000
Q2 2023 Aug 14, 2023	SELL	$9.62 - $13.99 $208,321 - $302,953	-21,655 Reduced 44.37%	27,149 $287,000
Q1 2023 May 15, 2023	BUY	$10.71 - $14.6 $138,416 - $188,690	12,924 Added 36.02%	48,804 $596,000
Q4 2022 Feb 13, 2023	BUY	$11.23 - $16.9 $103,461 - $155,699	9,213 Added 34.55%	35,880 $445,000
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $99,310 - $160,832	-8,269 Reduced 23.67%	26,667 $364,000
Q2 2022 Aug 11, 2022	SELL	$10.71 - $18.33 $46,620 - $79,790	-4,353 Reduced 11.08%	34,936 $640,000
Q1 2022 May 13, 2022	SELL	$11.78 - $16.98 $37,177 - $53,588	-3,156 Reduced 7.44%	39,289 $632,000
Q4 2021 Feb 11, 2022	SELL	$12.22 - $19.57 $39,458 - $63,191	-3,229 Reduced 7.07%	42,445 $594,000
Q3 2021 Nov 04, 2021	SELL	$15.42 - $21.72 $312,871 - $440,698	-20,290 Reduced 30.76%	45,674 $856,000
Q2 2021 Aug 11, 2021	BUY	$20.85 - $29.88 $437,266 - $626,643	20,972 Added 46.61%	65,964 $1.38 Million
Q1 2021 May 13, 2021	SELL	$24.75 - $39.14 $2.63 Million - $4.16 Million	-106,375 Reduced 70.28%	44,992 $1.27 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $2.51 Million - $3.6 Million	86,541 Added 133.5%	151,367 $4.94 Million
Q3 2020 Nov 12, 2020	BUY	$16.3 - $30.64 $35,452 - $66,642	2,175 Added 3.47%	64,826 $1.99 Million
Q2 2020 Aug 13, 2020	BUY	$7.95 - $18.81 $50,172 - $118,709	6,311 Added 11.2%	62,651 $1.02 Million
Q1 2020 May 14, 2020	SELL	$6.45 - $14.04 $119,131 - $259,318	-18,470 Reduced 24.69%	56,340 $561,000
Q4 2019 Feb 14, 2020	BUY	$12.97 - $15.94 $40,907 - $50,274	3,154 Added 4.4%	74,810 $1.03 Million
Q3 2019 Nov 14, 2019	SELL	$14.75 - $20.87 $79,664 - $112,718	-5,401 Reduced 7.01%	71,656 $1.09 Million
Q2 2019 Aug 14, 2019	BUY	$14.71 - $19.79 $878,922 - $1.18 Million	59,750 Added 345.24%	77,057 $1.52 Million
Q1 2019 May 15, 2019	SELL	$13.73 - $16.87 $5,656 - $6,950	-412 Reduced 2.33%	17,307 $285,000
Q4 2018 Feb 14, 2019	SELL	$10.6 - $17.49 $1.32 Million - $2.17 Million	-124,091 Reduced 87.51%	17,719 $248,000
Q3 2018 Dec 21, 2021	BUY	$16.65 - $21.85 $1.4 Million - $1.84 Million	84,298 Added 146.57%	141,810 $2.48 Million
Q3 2018 Nov 14, 2018	SELL	$16.65 - $21.85 $509,856 - $669,090	-30,622 Reduced 34.74%	57,512 $1 Million
Q2 2018 Apr 21, 2020	BUY	$14.8 - $18.8 $645,620 - $820,112	43,623 Added 98.0%	88,134 $1.6 Million
Q2 2018 Aug 14, 2018	SELL	$14.8 - $18.8 $813,215 - $1.03 Million	-54,947 Reduced 55.25%	44,511 $809,000
Q1 2018 Oct 18, 2019	BUY	$14.5 - $23.4 $917,125 - $1.48 Million	63,250 Added 174.69%	99,458 $1.86 Million
Q1 2018 May 15, 2018	SELL	$14.5 - $23.4 $252,836 - $408,025	-17,437 Reduced 32.5%	36,208 $677,000
Q4 2017 Feb 14, 2018	SELL	$13.5 - $16.65 $1.96 Million - $2.42 Million	-145,345 Reduced 73.04%	53,645 $819,000
Q3 2017 Nov 14, 2017	BUY	$6.05 - $14.95 $1.2 Million - $2.97 Million	198,990	198,990 $2.97 Million

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $747M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account